A Phase 3, Randomized, Multicenter, Multinational, Double-Blinded Study Comparing the Efficacy and Safety of Repeated Bi-Weekly Infusions ff neoGAA (GZ402666) and Alglucosidase Alfa in Treatment Naive Patients With Late Onset Pompe Disease"
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Genzyme Corporation
Start Date
September 1, 2016
End Date
May 18, 2023
Administered By
School of Medicine
Awarded By
Genzyme Corporation
Start Date
September 1, 2016
End Date
May 18, 2023